Sphera Funds Management Ltd. Xenon Pharmaceuticals Inc. Transaction History
Sphera Funds Management Ltd.
- $380 Million
- Q1 2025
A detailed history of Sphera Funds Management Ltd. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 26,097 shares of XENE stock, worth $837,452. This represents 0.23% of its overall portfolio holdings.
Number of Shares
26,097
Previous 52,097
49.91%
Holding current value
$837,452
Previous $2.04 Million
57.15%
% of portfolio
0.23%
Previous 0.42%
Shares
12 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
69.9MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$184 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$147 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$122 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$107 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$99.1 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...